NO20001847D0 - New use of compounds for anti-itch activity - Google Patents

New use of compounds for anti-itch activity

Info

Publication number
NO20001847D0
NO20001847D0 NO20001847A NO20001847A NO20001847D0 NO 20001847 D0 NO20001847 D0 NO 20001847D0 NO 20001847 A NO20001847 A NO 20001847A NO 20001847 A NO20001847 A NO 20001847A NO 20001847 D0 NO20001847 D0 NO 20001847D0
Authority
NO
Norway
Prior art keywords
compounds
new use
itch activity
itch
activity
Prior art date
Application number
NO20001847A
Other languages
Norwegian (no)
Other versions
NO20001847L (en
Inventor
Don Edgar Griswold
Iv Siegfried Benja Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20001847D0 publication Critical patent/NO20001847D0/en
Publication of NO20001847L publication Critical patent/NO20001847L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20001847A 1997-10-17 2000-04-10 New use of compounds for anti-itch activity NO20001847L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number Publication Date
NO20001847D0 true NO20001847D0 (en) 2000-04-10
NO20001847L NO20001847L (en) 2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001847A NO20001847L (en) 1997-10-17 2000-04-10 New use of compounds for anti-itch activity

Country Status (18)

Country Link
EP (1) EP1030666A4 (en)
JP (1) JP2001520196A (en)
KR (1) KR20010031149A (en)
CN (1) CN1306426A (en)
AR (1) AR015966A1 (en)
AU (1) AU740875B2 (en)
BR (1) BR9814080A (en)
CA (1) CA2306985A1 (en)
CO (1) CO4810374A1 (en)
CZ (1) CZ20001376A3 (en)
HU (1) HUP0003792A3 (en)
IL (1) IL135581A0 (en)
NO (1) NO20001847L (en)
NZ (1) NZ503551A (en)
PL (1) PL341062A1 (en)
TR (1) TR200001040T2 (en)
WO (1) WO1999020280A1 (en)
ZA (1) ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
IL156460A0 (en) 2001-01-31 2004-01-04 Pfizer Prod Inc Ether derivatives useful as inhibitors of pde4 isozymes
CZ20031895A3 (en) 2001-01-31 2004-08-18 Pfizeráproductsáinc Nicotinamide biaryl derivatives useful as PDE4 isozyme inhibitors
MXPA03006886A (en) 2001-01-31 2003-11-13 Pfizer Prod Inc Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes.
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
US20060258703A1 (en) * 2003-07-17 2006-11-16 Ono Pharmaceutical Co., Ltd. Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (en) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
JP2005187458A (en) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
EP1781657B1 (en) * 2004-02-14 2013-03-27 GlaxoSmithKline Intellectual Property Development Limited Medicaments with hm74a receptor activity
JP2008137892A (en) * 2005-03-04 2008-06-19 Eisai Co Ltd Antipruritic agent
KR20080038396A (en) 2005-08-10 2008-05-06 스미스클라인 비참 코포레이션 Xanthine derivatives as selective hm74a agonists
TWI404709B (en) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
PL1992622T3 (en) * 2006-02-21 2012-01-31 Eisai R&D Man Co Ltd 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
EP2123641A4 (en) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd Crystal, amorphous form and salt of methyl n-ý3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl¨terephthalamic acid
ATE538102T1 (en) 2007-08-17 2012-01-15 Eisai R&D Man Co Ltd METHOD FOR PRODUCING A QUINAZOLINE DERIVATIVE
WO2009025239A1 (en) 2007-08-17 2009-02-26 Eisai R & D Management Co., Ltd. Novel preparation for external use
ES2659458T3 (en) * 2011-06-28 2018-03-15 Mitsubishi Tanabe Pharma Corporation Naphthalene compounds to treat pruritus
KR102128810B1 (en) 2015-01-30 2020-07-02 샨톤 파르마 씨오., 엘티디. Prevention or treatment of uric acid or gout disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148170T3 (en) * 1990-12-21 2000-10-16 Beecham Group Plc XANTINA DERIVATIVES.
CA2250569C (en) * 1996-03-26 2005-05-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
ES2187775T3 (en) * 1996-05-15 2003-06-16 Altana Pharma Ag IMIDAZOPIRIDINS.
US6143759A (en) * 1997-03-07 2000-11-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrazoles
KR20000076420A (en) * 1997-03-18 2000-12-26 스타르크, 카르크 Methods and compositions for modulating responsiveness to corticosteroids
WO1998055481A1 (en) * 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Also Published As

Publication number Publication date
AR015966A1 (en) 2001-05-30
CN1306426A (en) 2001-08-01
TR200001040T2 (en) 2001-01-22
KR20010031149A (en) 2001-04-16
PL341062A1 (en) 2001-03-26
NO20001847L (en) 2000-04-10
ZA989450B (en) 1999-04-19
CZ20001376A3 (en) 2002-06-12
JP2001520196A (en) 2001-10-30
IL135581A0 (en) 2001-05-20
EP1030666A1 (en) 2000-08-30
HUP0003792A3 (en) 2001-12-28
CA2306985A1 (en) 1999-04-29
WO1999020280A1 (en) 1999-04-29
BR9814080A (en) 2000-09-26
EP1030666A4 (en) 2002-10-16
AU1093899A (en) 1999-05-10
AU740875B2 (en) 2001-11-15
NZ503551A (en) 2002-05-31
HUP0003792A2 (en) 2001-10-28
CO4810374A1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
CY2012029I2 (en) NEW FORM OF 5-OMEPRAZOLE
IS5354A (en) New compounds
ID24372A (en) COMPOUNDS OF 4-AMINO-TIAZOL-2-IL COMPOUNDS AS CDKERS
IS5338A (en) New Spiroasabicyclic Heterocyclic Compounds
FI972292A (en) Management of diabetes
ID24638A (en) COMPOUNDS OF ANTI ARYTHMIA BISPIDINA
NO20015855D0 (en) New use of compounds as antibacterial agents
NO20001847D0 (en) New use of compounds for anti-itch activity
NO993298L (en) New procedure
ID24677A (en) COMBINATION OF FUNICIDAL ACTIVE COMPOUNDS
ID29966A (en) SULFONYLOKSAZOLAMINA-SULFONYLOKSAZOLAMINA AS ACTIVE COMPOUNDS OF THERAPY
NO995796L (en) New procedure
ID24270A (en) REMOVAL OF KERATOTIC CONSTITIONS
NO996438D0 (en) New combination of asthma drugs
EE200000055A (en) Process for the preparation of cyclopropylacetylene
FI963532A0 (en) New use of quinoline-3-carboxamide compounds
FI963531A (en) New use of quinoline-3-carboxamide compounds
ID24694A (en) USAGE OF SUBSTANCE AS CATALYST FOR THE MAKING OF CAPROLAKTAM
ID24439A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
ID19787A (en) COMPOUND 25-HYDROXY-16-ENA-26,27-BISHOMO-COLLECTION OF FERROL
ID24521A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
NO963762D0 (en) New use of quinoline-3-carboxamide compounds
NO963764D0 (en) New use of quinoline-3-carboxamide compounds
SE9702535D0 (en) New compounds
SE9704837D0 (en) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application